Code | CSB-E08003h |
Size | $450 |
Order now | |
Promotion | |
Trial Size |
24T ELISA Kit Trial Size (Only USD$150/ kit) * Sample kit cost can be deducted as a $30 credit for each 96-assay kit of the same analyte and brand you subsequently purchase within six months until depleted. More details >> Interested in a trial size? Please leave a message below.
|
Have Questions? | Leave a Message or Start an on-line Chat |
Intra-assay Precision (Precision within an assay): CV%<8%
Three samples of known concentration were tested twenty times on one plate to assess.
Inter-assay Precision (Precision between assays):CV%<10%
Three samples of known concentration were tested in twenty assays to assess.
To assess the linearity of the assay, samples were spiked with high concentrations of human Timp-1 in various matrices and diluted with the Sample Diluent to produce samples with values within the dynamic range of the assay.
These standard curves are provided for demonstration only. A standard curve should be generated for each set of samples assayed.
The human tissue inhibitor of matrix metalloprotease-1 (TIMP1) ELISA kit is suitable for the quantitative determination of human TIMP1 in serum, plasma, or tissue homogenates. This assay employs the bi-antibody sandwich technique and enzyme-substrate chromogenic reaction to quantify human TIMP1 levels in the sample. The amount of synthesized colored product is positively related to the analyte of interest in the sample.
TIMP1 is a glycoprotein produced by cardiac myocytes and fibroblasts in the normal heart. TIMP1 binds with active MMPs to inhibit MMP activity. In addition to suppressing MMP activity, TIMP1 also regulates multiple biological activities, including inhibiting apoptosis, stimulating cell proliferation and differentiation, as well as promoting migration and angiogenesis or the metastatic potential of tumor cells. Overexpression of TIMP1 has been found in several types of human cancers, including prostate cancer, lung cancer, melanoma, glioblastoma, and breast cancer. TIMP1 acting as a specific hallmark of human cancer is also associated with the tumor microenvironment (TME) and drug resistance.
There are currently no reviews for this product.